NEAR Protocol's NEAR Intents service has added support for swapping the PEARL token with other assets across multiple blockchain networks. This cross-chain trading protocol has achieved a significant milestone with over $31 billion in cumulative transaction volume. The update enhances users' ability to trade PEARL seamlessly, reflecting growing adoption and liquidity in the NEAR ecosystem. This development could further boost cross-chain asset exchange and user engagement on NEAR Protocol.
NEAR Protocol's NEAR Intents service expansion is noted here with Pluang's market snapshot for context. For readers following cryptocurrency markets, as of Nov 05, 2026 13:01 WIB, 42 of 50 major cryptocurrencies on Pluang rose while 7 fell. Notable price changes include EOS up 8.13% at Rp12.649 with a typical hold time of 87 days, XTZ up 7.43% at Rp4.856 with 100% buy order activity and a 101-day hold, and CAKE up 7.28% at Rp36.523 with 65% sell order activity and a 75-day hold.
Futu Holdings Limited will announce its financial results for the third quarter ending September 30, 2026, on November 19 before U.S. market open. The company will host a live earnings conference call at 7:30 AM ET (8:30 PM Beijing/Hong Kong time) th...
Lorenz Snacks has introduced a fleet of four autonomous, electric vehicles from Einride at its production site in Neunburg vorm Wald, Germany. These vehicles will handle in-plant transport of goods and materials, replacing diesel trucks and significa...
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...
Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...
